Skip to main content

Advertisement

Table 2 Demographic characteristics of the participants

From: Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres

Variable Total ID 2500 IV 50 IV 200 IV 800 IV 3200 DVI 3200
N 36 6 3 3 9 9 6
Age in years* 26 (19; 43) 24 (21; 42) 24 (23; 27) 27 (27; 32) 26 (21; 43) 27 (24; 30) 29 (19; 40)
Gender, Female:Male# 11:25 1:5 0:3 0:3 4:5 2:7 4:2
Height in cm* 176 (159; 196) 178 (166; 196) 186 (178; 190) 169 (167; 186) 177 (166; 189) 176 (163; 196) 167 (159; 172)
Weight in kg* 73 (55; 111) 83 (63; 92) 77 (70; 100) 77 (68; 82) 74 (59; 90) 71 (64; 111) 61.1 (55; 73)
BMI in kg/m2* 23.9 (18.5; 29.4) 24.1 (22.9; 29.4) 22.1 (21.3; 28.9) 24.3 (22.3; 28.7) 23.8 (19.1; 26.6) 24.1 (18.5; 28.8) 22.8 (19.1; 24.8)
Hb in g/dl* 14.7 (11.8; 16.7) 15.1 (12.5; 15.3) 15.6 (15.1; 16.2) 16.1 (14.7; 16.7) 14.2 (12.0; 16.6) 14.6 (11.8; 15.7) 13.3 (12.3; 15.1)
Platelets/nL* 248 (138; 396) 231 (172; 260) 237 (138; 340) 263 (210; 307) 221 (176; 261) 246 (193; 396) 321 (259; 364)
  1. *Median (min; max), #N, ID: intradermal, IV: intravenous (dose-escalation group), DVI: direct venous inoculation (verification group).